Lehman & Derafelo Financial Resources’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.3M | Sell |
26,777
-800
| -3% | -$68.7K | 0.68% | 23 |
|
|
2022
Q3 | $1.7M | Buy |
27,577
+600
| +2% | +$37K | 0.54% | 26 |
|
|
2022
Q2 | $1.67M | Buy |
26,977
+1,190
| +5% | +$73.5K | 0.52% | 26 |
|
|
2022
Q1 | $1.53M | Buy |
25,787
+1,087
| +4% | +$64.6K | 0.43% | 39 |
|
|
2021
Q4 | $1.79M | Buy |
24,700
+120
| +0.5% | +$8.71K | 0.54% | 30 |
|
|
2021
Q3 | $1.72M | Buy |
24,580
+250
| +1% | +$17.5K | 0.56% | 31 |
|
|
2021
Q2 | $1.68M | Buy |
24,330
+150
| +0.6% | +$10.3K | 0.46% | 33 |
|
|
2021
Q1 | $1.56M | Sell |
24,180
-300
| -1% | -$19.4K | 0.44% | 36 |
|
|
2020
Q4 | $1.43M | Buy |
24,480
+790
| +3% | +$46K | 0.43% | 37 |
|
|
2020
Q3 | $1.5M | Buy |
23,690
+655
| +3% | +$41.4K | 0.48% | 28 |
|
|
2020
Q2 | $1.77M | Buy |
23,035
+75
| +0.3% | +$5.77K | 0.62% | 29 |
|
|
2020
Q1 | $1.72M | Buy |
22,960
+1
| +0% | +$75 | 0.71% | 27 |
|
|
2019
Q4 | $1.49M | Buy |
22,959
+151
| +0.7% | +$9.81K | 0.54% | 35 |
|
|
2019
Q3 | $1.45M | Buy |
22,808
+1
| +0% | +$63 | 0.55% | 35 |
|
|
2019
Q2 | $1.56M | Sell |
22,807
-499
| -2% | -$34.2K | 0.64% | 33 |
|
|
2019
Q1 | $1.52M | Buy |
23,306
+1,501
| +7% | +$97.6K | 0.65% | 32 |
|
|
2018
Q4 | $1.36M | Buy |
+21,805
| New | +$1.36M | 0.68% | 30 |
|